{"schema_version":"secwatch.filing_event.v1","accession":"0000096943-25-000025","form_type":"8-K","ticker":"TFX","cik":"0000096943","company_name":"TELEFLEX INC","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.925692+00:00","generated_at":"2026-05-26T03:01:36.027254+00:00","sec_items":["1.01","2.03","2.02","5.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Teleflex reports Q4 adj EPS $3.89 (+15%); plans two-company split and BIOTRONIK acquisition","bullets":["Q4 GAAP EPS from cont. ops. $(2.95) vs $0.66; adj EPS $3.89 vs $3.38 (+15.1%). Full-year adj EPS $14.01.","2025 guidance: adj EPS $13.95-$14.35; adj constant currency revenue growth 1%-2%.","Plans tax-free separation into RemainCo (Vascular Access, Interventional, Surgical) and NewCo (Urology, Acute Care, OEM); completion expected mid-2026.","Definitive agreement to acquire substantially all of BIOTRONIK's Vascular Intervention business; $500M delayed draw term loan facility secured.","CFO Thomas Powell retiring Apr 1, 2025; John R. Deren succeeds as EVP & CFO effective Apr 2, consulting for one year."],"urls":{"canonical":"https://secwatch.observer/filing/0000096943-25-000025","json":"https://secwatch.observer/filing/0000096943-25-000025.json","markdown":"https://secwatch.observer/filing/0000096943-25-000025.md","text":"https://secwatch.observer/filing/0000096943-25-000025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/96943/000009694325000025/0000096943-25-000025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/96943/000009694325000025/tfx-20250224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T03:01:36.027254+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4700670af5","claim":"Thomas E. Powell retired as Executive Vice President and Chief Financial Officer at TELEFLEX INC.","evidence_excerpt":"who on February 24, 2025 informed the Company that he will retire as Executive Vice President and Chief Financial Officer of the Company, effective April 1, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/96943/000009694325000025/0000096943-25-000025-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"4eaab5ec1f","claim":"John R. Deren was appointed as Executive Vice President and Chief Financial Officer at TELEFLEX INC.","evidence_excerpt":"the Company’s Board of Directors appointed John R. Deren, 57, who has served as the Company’s Corporate Vice President and Chief Accounting Officer since May 2017, to serve as Executive Vice President and Chief Financial Officer of the Company, effective April 2, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/96943/000009694325000025/0000096943-25-000025-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}